News and Events

  • Complement Biomarkers for Alcoholic Liver Disease Research

    Posted: May 17, 2021

    It’s Not Just Support. It’s Solutions. DiaPharma has the tools for your alcoholic liver disease research   Complement Biomarkers for Alcoholic Hepatitis The complement system is a critical component of the immune system that aids in the body’s defense against bacterial and/or viral infections. However, excessive activation of the complement system can result in uncontrolled…

    Read More

  • INRoads to researching liver disease and coagulation

    Posted: April 29, 2021

    It’s Not Just Support. It’s Solutions. DiaPharma has the tools for your Liver Disease Coagulopathy Research   Markers of Hemostasis Liver diseases such as acute fatty liver or cirrhosis can be associated with imbalances in coagulation, whether due to defects of platelet count/function, decrease in synthesis of coagulation factors, decrease in clearance of activated coagulation…

    Read More

  • Now available, Anti-Human HbS (Clone 57-8) for flow cytometry

    Posted: April 29, 2021

    It’s Not Just Support. It’s Solutions. Distribution Matters: Measure Using Flow Cytometry   Anti-Hemoglobin S antibody now available! IQ Products, of the Netherlands, just released a new monoclonal antibody for detection of HbS in flow cytometry applications. Now, researchers can accurately measure HbS distribution within a sample with no overlapping HPLC peaks to allow for…

    Read More

  • Contact System Cross-Talk: Tools for Investigating Contact Activation Pathway

    Posted: April 23, 2021

    It’s Not Just Support. It’s Solutions. DiaPharma has the tools for your Contact Activation Research Contact Activation and its role in coagulation, anticoagulation, and inflammation The contact activation pathway has been investigated as a target for potential pharmaceutical drugs. Its interactions in coagulation, anticoagulation, fibrinolysis, complement and inflammation make it complex but attractive for therapeutic…

    Read More

  • T-TAS®01 – The Leading Edge in Primary Hemostasis Assessment

    Posted: March 22, 2021

    It’s Not Just Support. It’s Solutions. Discover the Leading Edge in Primary Hemostasis Assessment Global evaluation of overall hemostatic ability using physiologic, flow conditions. Exclusively from DiaPharma. Advantages of T-TAS® 01 Ease of Interpretation A numeric cut-off easily identifies those with primary hemostasis disorders, assisting with more timely determination of appropriate treatment strategy Reduced Costs…

    Read More

  • What’s New at DiaPharma?

    Posted: March 3, 2021

    It’s Not Just Support. It’s Solutions.   Meet the Team Tinu Adewole East Territory Manager Tinu has been with DiaPharma since July 2013. She enjoys staying healthy and active, these days by working with a virtual Personal Trainer, taking walks in the neighborhood, and doing online YouTube pilates & yoga videos. She says, “It took…

    Read More

  • Insights into an Imbalanced vWF antigen to ADAMTS-13 activity ratio in COVID-19

    Posted: February 12, 2021

    – Contributed by Abi Kasberg, PhD   One of the many complicated outcomes associated with severe cases of COVID-19 is the high occurrence of thrombotic and microthrombotic events. SARS-CoV-2-induced endothelial injury drives elevated inflammatory responses that promote dysregulated coagulation systems, in a condition named COVID-19-associated coagulopathy (CAC). The severity of CAC is associated with the…

    Read More

  • PKA Products for Reliable, Convenient IVIG and Albumin Safety Testing

    Posted: February 2, 2021

    Immunoglobulin Testing Assays Reliable, convenient testing for procoagulant contaminants Diapharma offers a variety of products for sensitive quality control and safety testing to ensure removal of thrombogenic agents in IVIG and Albumin preparations.   Prekallikrein Activity Assays Specialty Range of PKA Assay Kits, Reagents & Controls Fractionation of Human plasma to produce Human Albumin and…

    Read More

  • Complement Your TMA Research

    Posted: January 12, 2021

    COUNT ON DIAPHARMA for a Complete Portfolio of Thrombotic Microangiopathy (TMA) Research Products   ADAMTS13 Measurement Technozym ADAMTS13 Activity ELISA for determination of ADAMTS13 activity Calibrators & Controls traceable to WHO 1st International Standard ADAMTS13 plasma No interference by bilirubin, hemolytic, or lipemic samples Use for ADAMTS13 inhibitor determination in Bethesda Assay Technozym ADAMTS13 Inhibitor…

    Read More